Work

Peptide receptor radionuclide therapy (PRRT) transcriptomic signature in blood for prediction of 177lu-octreotate efficacy.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.4101

Authors: Lisa Bodei, Mark S. Kidd, Aviral Singh, Wouter A van der Zwan, Stefano Severi, Ignat Drozdov, Jaroslaw B Cwikla, Richard P. Baum, Dik J. Kwekkeboom, Giovanni Paganelli, Eric Krenning, Irvin Mark Modlin

Institutions: Memorial Sloan Kettering Cancer Center, Yale University, Zentralklinik Bad Berka, Erasmus MC, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Wren Laboratories (United States), University of Warmia and Mazury in Olsztyn

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891355226

Cites:

Cited by: 1

Related to: 10